Personal tools

MCL coexpression mm9:508: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002370!5.80e-40!23;UBERON:0000974!5.80e-40!23;UBERON:0004807!5.80e-40!23;UBERON:0005058!5.80e-40!23;UBERON:0003351!5.80e-40!23;UBERON:0009113!5.80e-40!23;UBERON:0003295!5.80e-40!23;UBERON:0009722!5.80e-40!23;UBERON:0005562!5.80e-40!23;UBERON:0007690!5.80e-40!23;UBERON:0006562!4.14e-38!24;UBERON:0003408!4.14e-38!24;UBERON:0001557!4.14e-38!24;UBERON:0001042!4.14e-38!24;UBERON:0008814!4.14e-38!24;UBERON:0009145!4.14e-38!24;UBERON:0004177!4.53e-34!29;UBERON:0005057!4.53e-34!29;UBERON:0000072!2.25e-33!27;UBERON:0000077!2.02e-27!35;UBERON:0002193!2.86e-25!48;UBERON:0002405!2.86e-25!48;UBERON:0002390!8.08e-25!45;UBERON:0003061!8.08e-25!45;UBERON:0000063!1.03e-24!35;UBERON:0007811!6.68e-24!36;UBERON:0000065!1.95e-20!41;UBERON:0001004!7.65e-20!42;UBERON:0000153!2.82e-19!43;UBERON:0003929!4.29e-14!55;UBERON:0002368!1.50e-12!60;UBERON:0002530!3.03e-11!65;UBERON:0000490!5.23e-11!66;UBERON:0003081!2.16e-10!87;UBERON:0005911!2.44e-10!69;UBERON:0000949!1.00e-09!72;UBERON:0002384!1.48e-09!46;UBERON:0001041!2.24e-09!80;UBERON:0000064!1.71e-08!99
|ontology_enrichment_uberon=UBERON:0002370!5.80e-40!23;UBERON:0000974!5.80e-40!23;UBERON:0004807!5.80e-40!23;UBERON:0005058!5.80e-40!23;UBERON:0003351!5.80e-40!23;UBERON:0009113!5.80e-40!23;UBERON:0003295!5.80e-40!23;UBERON:0009722!5.80e-40!23;UBERON:0005562!5.80e-40!23;UBERON:0007690!5.80e-40!23;UBERON:0006562!4.14e-38!24;UBERON:0003408!4.14e-38!24;UBERON:0001557!4.14e-38!24;UBERON:0001042!4.14e-38!24;UBERON:0008814!4.14e-38!24;UBERON:0009145!4.14e-38!24;UBERON:0004177!4.53e-34!29;UBERON:0005057!4.53e-34!29;UBERON:0000072!2.25e-33!27;UBERON:0000077!2.02e-27!35;UBERON:0002193!2.86e-25!48;UBERON:0002405!2.86e-25!48;UBERON:0002390!8.08e-25!45;UBERON:0003061!8.08e-25!45;UBERON:0000063!1.03e-24!35;UBERON:0007811!6.68e-24!36;UBERON:0000065!1.95e-20!41;UBERON:0001004!7.65e-20!42;UBERON:0000153!2.82e-19!43;UBERON:0003929!4.29e-14!55;UBERON:0002368!1.50e-12!60;UBERON:0002530!3.03e-11!65;UBERON:0000490!5.23e-11!66;UBERON:0003081!2.16e-10!87;UBERON:0005911!2.44e-10!69;UBERON:0000949!1.00e-09!72;UBERON:0002384!1.48e-09!46;UBERON:0001041!2.24e-09!80;UBERON:0000064!1.71e-08!99
|tfbs_overrepresentation_for_novel_motifs=0.224466,0.462564,0.204219,0.25808,0.391122,0.269875,0.346405,0.0669598,0.251553,0.236908,0.308886,0.336042,0.511203,0.357027,0.134875,0,0.530547,1.24126,0.470307,0.465097,0.176628,0.329508,0.937489,0.388504,0.210021,0.381085,0.781016,0.287195,0.154744,0.338204,0.275529,0.624931,0.373899,0.176308,0.135203,0.0302663,0.111136,0.332941,0.322338,0.0808072,0.121091,0.279796,0.145909,0.423138,0.314995,0.24907,0.457618,0.300372,1.25814,0.156829,0.514446,1.04423,0.584697,0.759566,0.776306,0.363247,0.163199,0.325117,0.190698,0.36147,0.606104,0.413233,0.0784106,0.504093,0.372973,0.541429,0.908031,1.25063,0.60172,1.10561,0.189925,0.246154,0.0681764,0.808562,0.181606,0.37844,0.17621,0.447339,0.590017,0.179738,0.247973,0.546623,0.411949,0.227715,0.69807,0.00290338,5.57794,0.958261,0.462057,1.41118,0.975915,0.702809,1.5387,0.401201,0.0951738,1.5019,0.233568,0.639644,0.457849,1.21972,0.358446,0.624668,0.742871,0.514993,0.514023,0.279432,0.569344,0.296997,0.539826,0.177945,0.218949,0.744577,1.02113,0.313258,0.982794,0.381263,0.189757,0.26114,0.53175,1.17709,0.813766,1.21719,0.382687,1.13466,1.03573,0.593478,0.353461,1.52534,0.906557,1.31219,0.726634,1.29819,0.877862,0.375176,1.0039,3.48353,0.231086,0.280962,0.955897,1.77738,1.3796,0.91261,0.393303,0.634793,0.508066,0.280171,0.460443,1.73788,1.22575,0.124893,0.148959,0.0106906,0.761071,0.29706,0.374365,0.839715,0.405736,0.143092,0.633366,0.230865,0.96517,0.697256,0.593895,0.21719,0.50503,0.367885,0.722157,0.33468,0.0249603
}}
}}

Revision as of 18:28, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:13713621..13713634,+p@chr10:13713621..13713634
+
Mm9::chr15:66633139..66633161,-p4@Sla
Mm9::chr16:78559794..78559797,-p@chr16:78559794..78559797
-
Mm9::chr17:35804606..35804622,+p@chr17:35804606..35804622
+
Mm9::chr19:10793612..10793616,-p@chr19:10793612..10793616
-
Mm9::chr19:10793908..10793920,-p@chr19:10793908..10793920
-
Mm9::chr19:29597656..29597665,-p1@A930007I19Rik
Mm9::chr19:34291685..34291717,+p5@Stambpl1
Mm9::chr1:36836791..36836797,+p@chr1:36836791..36836797
+
Mm9::chr6:41091281..41091292,+p@chr6:41091281..41091292
+
Mm9::chr6:41091296..41091306,+p@chr6:41091296..41091306
+
Mm9::chr7:148514080..148514108,-p4@Deaf1
Mm9::chr7:85864254..85864265,+p@chr7:85864254..85864265
+
Mm9::chr7:85864308..85864335,+p@chr7:85864308..85864335
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
lymphoid lineage restricted progenitor cell2.58e-2512
mature alpha-beta T cell1.61e-239
alpha-beta T cell1.61e-239
immature T cell1.61e-239
mature T cell1.61e-239
immature alpha-beta T cell1.61e-239
lymphocyte3.45e-2313
common lymphoid progenitor3.45e-2313
T cell3.88e-2311
pro-T cell3.88e-2311
CD4-positive, alpha-beta T cell3.27e-218
nucleate cell2.10e-1816
leukocyte3.47e-1717
nongranular leukocyte3.47e-1717
thymocyte2.06e-166
double negative thymocyte2.06e-166
naive T cell2.06e-166
double-positive, alpha-beta thymocyte2.06e-166
CD4-positive, alpha-beta thymocyte2.06e-166
naive thymus-derived CD4-positive, alpha-beta T cell2.06e-166
DN4 thymocyte2.06e-166
DN1 thymic pro-T cell2.06e-166
DN2 thymocyte2.06e-166
DN3 thymocyte2.06e-166
immature single positive thymocyte2.06e-166
early T lineage precursor2.06e-166
mature CD4 single-positive thymocyte2.06e-166
resting double-positive thymocyte2.06e-166
double-positive blast2.06e-166
CD69-positive double-positive thymocyte2.06e-166
CD69-positive, CD4-positive single-positive thymocyte2.06e-166
CD4-positive, CD8-intermediate double-positive thymocyte2.06e-166
CD24-positive, CD4 single-positive thymocyte2.06e-166
hematopoietic lineage restricted progenitor cell2.37e-1525
hematopoietic cell3.53e-1532
hematopoietic oligopotent progenitor cell3.53e-1532
hematopoietic stem cell3.53e-1532
angioblastic mesenchymal cell3.53e-1532
hematopoietic multipotent progenitor cell3.53e-1532
connective tissue cell1.48e-0946
mesenchymal cell1.48e-0946
motile cell1.15e-0754

Uber Anatomy
Ontology termp-valuen
thymus5.80e-4023
neck5.80e-4023
respiratory system epithelium5.80e-4023
hemolymphoid system gland5.80e-4023
pharyngeal epithelium5.80e-4023
thymic region5.80e-4023
pharyngeal gland5.80e-4023
entire pharyngeal arch endoderm5.80e-4023
thymus primordium5.80e-4023
early pharyngeal endoderm5.80e-4023
pharynx4.14e-3824
gland of gut4.14e-3824
upper respiratory tract4.14e-3824
chordate pharynx4.14e-3824
pharyngeal arch system4.14e-3824
pharyngeal region of foregut4.14e-3824
hemopoietic organ4.53e-3429
immune organ4.53e-3429
segment of respiratory tract2.25e-3327
mixed endoderm/mesoderm-derived structure2.02e-2735
hemolymphoid system2.86e-2548
immune system2.86e-2548
hematopoietic system8.08e-2545
blood island8.08e-2545
organ segment1.03e-2435
craniocervical region6.68e-2436
respiratory tract1.95e-2041
respiratory system7.65e-2042
anterior region of body2.82e-1943
gut epithelium4.29e-1455
endocrine gland1.50e-1260
gland3.03e-1165
unilaminar epithelium5.23e-1166
lateral plate mesoderm2.16e-1087
endo-epithelium2.44e-1069
endocrine system1.00e-0972
connective tissue1.48e-0946
foregut2.24e-0980
organ part1.71e-0899


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}